Inhibition of ubiquitin-proteasome pathway-mediated IκBα degradation by a naturally occurring antibacterial peptide

Journal of Clinical Investigation

Volumn 106, Issue 3, 2000, Pages 439-448

  Gao, Youhe ^a   Lecker, Stewart ^b   Post, Mark J ^a   Hietaranta, Antti J ^a   Li, Jian ^a   Volk, Rudiger ^a   Li, Min ^a   Sato, Kaori ^a   Saluja, Ashok K ^a   Steer, Michael L ^a   Goldberg, Alfred L ^b   Simons, Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CERULETIDE; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERCELLULAR ADHESION MOLECULE 1; LACTACYSTIN; PROTEASOME; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SYNTHETIC PEPTIDE; UBIQUITIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE INDUCTION; HEART INFARCTION SIZE; HELA CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

EID: 0033847049     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9826     Document Type: Article

References (58)

1. New insights into the mechanisms and importance of the proteasome in intracellular protein degradation
2. Molecular biology of the proteasome
3. The proteasome: Paradigm of a self-compartmentalizing protease
4. Structure and functions of the 20S and 26S proteasomes
5. The proteasome, a novel protease regulated by multiple mechanisms
6. I kappa B proteins: Structure, function and regulation
7. Hypoxia-inducible factor 1 (HIF-1) is a non-heme iron protein. Implications for oxygen sensing
8. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
9. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
10. C-Fos degradation by the proteasome. An early, bcl-2-regulated step in apoptosis
11. Control of gene expression by proteolysis
12. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation ofNF-kappa B
13. Degradation of cell proteins and the generation of MHC class I-presented peptides
14. Proteasome inhibitors: Valuable new tools for cell biologists
15. NF-kappa B: Ten years after
16. An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
17. Suppression of TNF-alpha-induced apoptosis by NF-kappa B
18. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity
19. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination
20. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP
21. Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP
22. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase
23. Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation ofIkappaBalpha
24. Involvement of valosin-containing protein, an ATPase co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation ofIkappaBalpha
25. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family ofproline-arginine-rich anti-bacterial peptides
26. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: Comparative mapping of the locus for the human peptide antibiotic FALL-39
27. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox
28. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130 (Cas)
29. A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39
30. Macrophage-dependent regulation of syndecan gene expression
31. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds
32. PR39, a peptide regulator of angiogenesis
33. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
34. Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha
35. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line
36. The role of intercellular adhesion molecule i and neutrophils in acute pancreatitis and pancreatitis-associated lung injury
37. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis
38. Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor
39. Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart
40. Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation
41. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance
42. Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae
43. Lactacystin, proteasome function, and cell fate
44. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion
45. Tumor necrosis factor in the heart
46. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers
47. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B
48. Cardioprotectire effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart
49. Myocardial ischemia-teperfusion injury in CD18- and ICAM-1-deficient mice
50. Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-teperfusion injury in mice
51. Monoclonal antibody to ICAM- 1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit
52. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21
53. C-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis
54. Proteasome inhibitors: A novel class of potent and effective antitumor agent
55. The human proteasomal subunit HsC8 induces ring formation of other alpha-type subunits
56. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit
57. HIV-1 tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation
58. Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome